Bone Densitometer Market

Global Bone Densitometer Market Size (2024 to 2029)

The global bone densitometer market size is valued at USD 326.56 million in 2024 and is anticipated to reach USD 417.99 million by 2029 with a CAGR of 4.2% during the forecast period. 

The densitometer is a light source that determines the sample density, which is placed between the light source and the photoelectric cell. The bone density test is used to measure the bone mineral content and density. Bone density test is primarily used to diagnose osteopenia and osteoporosis and to detect future fracture risk. Early treatment or diagnosis of osteoporosis and osteopenia helps prevent bone fractures, so bone densitometry is necessary for people. 

Global Bone Densitometer Market Drivers:

The growing geriatric population worldwide is increasing the cases of osteoporosis and vitamin D deficiency, which demand bone densitometers for measuring bone density, primarily contributing to the growth of the global bone densitometer market. Age-related bone loss in people often leads to osteoporosis. Bone densitometers help healthcare professionals by guiding appropriate preventive measures, diagnosis, and treatment strategies, which is raising the adoption of bone densitometers by enhancing the global market revenue. The accurate assessment of the bone densitometer helps prevent risk factors, monitor and plan treatment, improve patients, and fuel global market expansion. The increasing prevalence of vitamin D and calcium deficiency among people worldwide and the growing chemotherapy treatment among people with various cancers affect the bone density of the patient; all these factors are propelling the global bone densitometer adoption, which positively impacts the global market value. Women are expected to be highly prone to osteoporosis compared to men due to the presence of short and lighter bones than men. According to the World Health Organization (WHO), osteoporosis affects 6.3% of men and 21.2% of women globally over 50 years of age. The International Osteoporosis Foundation estimates that there are more than 8.9 million fractures per year globally, and osteoporosis affects about 200 million postmenopausal women worldwide. These reasons are raising the adoption rate of bone densitometers for preventive measures, diagnosis, and treatment strategies, boosting the global bone densitometer market growth. 

The growing number of trauma cases where bone problems are highly observed is increasing the demand for bone densitometers as the long-term recovery period shows the bone issues. The rising adoption of a sedentary lifestyle with unhealthy food habits is showing the impact on malnutrition, which is leading to bone problems irrespective of age, and osteoporosis is widely observed. All these factors are escalating the global bone densitometer market revenue with a wide range of adoption to test bone density. 

The increasing government initiatives in collaboration with NGOs to bring awareness among the people regarding the risks of osteoporosis and preventive measures, diagnosis, and treatment options are expected to raise the market growth opportunities. The emerging market trends in developing countries will offer significant growth opportunities for market players in the bone densitometers market in the forecast period. The increasing disposable incomes of people are allowing them to invest more in healthcare, which fuels the growth of the global market. The growing technological advancements in bone densitometer devices are expected to increase the safety and efficacy of the devices, increasing their adoption among people by enhancing the global market share in the forecast period.

Global Bone Densitometer Market Restraints:

The high cost of bone densitometer devices such as Dual-energy X-ray absorptiometry (DEXA) is considered standard for measuring bone mineral density. The expensive devices are difficult to afford for small and medium-sized hospitals due to controlled budgets, which is expected to hamper the global bone densitometer expansion. Most healthcare facilities purchase expensive equipment by depending on third-party payers for reimbursements during these systems diagnosis, screening, and therapeutic procedures. This kind of action by the hospitals is expected to limit global market revenue growth due to frequent cuts in reimbursements for testing and diagnosis of bone density. 

There is a need for more awareness among people in low- and middle-income countries regarding the benefits of bone densitometers, as most osteoporosis cases are left untreated in these countries. The requirement of skilled professionals for operating bone densitometer devices is challenging for the market expansion with limited professionals. The risks associated with the usage of bone densitometers, such as a slight risk of cancer due to high radiation exposure, are expected to limit the expansion of the global market.

Impact of COVID-19 on the bone densitometer market:

The Pandemic had a mixed impact on the bone densitometers market as the stringent lockdown regulations led to supply chain disruptions and production delays. There is an increased focus on emergency COVID-19 patients by canceling the other non-emergency diagnostics tests and treatment procedures to avoid spreading infection. However, post-pandemic increased the adoption of bone densitometers as the people recovered from COVID-19 were frequently assessed with the early detection and management of osteoporosis issues, which increased the demand for bone densitometers. National Library of Medicine in 2022 reported that COVID-19's post-acute sequela can result in secondary osteoporosis. 

REPORT COVERAGE:

This research report on the bone densitometer market has been segmented and sub-segmented based on type, technology, application, end-use and region.

Global Bone Densitometer Market - By Type:

• Axial Bone Densitometers
• Peripheral Bone Densitometers

The axial bone densitometers segment held the largest market share globally due to the wide use of densitometers in this technique. The growing prevalence of orthopedic patients is increasing the adoption of axial bone densitometers as they satisfy the clinical criteria, leading to segment growth that positively impacts the global bone densitometer market revenue. 

Global Bone Densitometer Market - By Technology:

• Quantitative Ultrasound (QUS)
• Dual Energy X-ray absorptiometry (DEXA)
• Absorptiometry (DXA)
• Peripheral Dual Energy X-Ray 
• Others

The dual energy x-ray absorptiometry segment dominated the global market revenue with the largest market share and is expected to have a significant CAGR during the forecast period. The DEXA technique is highly used in axial bone densitometry, driving segment growth. 

The absorptiometry segment is expected to have prominent growth during the forecast period as these are affordable and adopted diversely among hospitals. 

Global Bone Densitometer Market - By Application:

• Osteoporosis & Osteopenia Diagnosis
• Rheumatoid Arthritis Diagnosis
• Chronic Kidney Diseases Diagnosis
• Body Composition Measurement
• Cystic Fibrosis Diagnosis

The osteoporosis and osteopenia diagnosis segment dominated the global market revenue with a significant share and is anticipated to dominate during the forecast period. Osteoporosis and osteopenia are the common bone conditions observed in the geriatric population, and the growing prevalence of these conditions boosts the global market expansion in this segment. Bone densitometers are essential in assessing fracture risks with osteoporosis and osteopenia, fueling segment growth in the upcoming years. Using the bone densitometers, the bone mineral density is measured at specific sites such as the hip and spine, which helps prevent fracture risks. 

Global Bone Densitometer Market - By End-Use:

• Hospitals
• Speciality Centers
• Others

The hospital segment dominated the global market with a market share of 48% in 2023 due to increasing support from government organizations in promoting advanced diagnostic tools that provide rapid results. Hospitals are equipped with advanced technology devices and skilled healthcare professionals, which helps in the early detection of disease conditions. Hospitals play an important role in detecting and managing osteoporosis, which drives the segment growth. 

Global Bone Densitometer Market - By Region:

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East and Africa

The North American region held the largest global market share and is anticipated to maintain significant growth during the forecast period. The increasing geriatric population in countries like the U.S. and Canada and the presence of advanced healthcare infrastructure are fueling regional market growth. The growing prevalence of bone and joint cancers across the region is demanding bone densitometers. According to the American Cancer Society, there will be 3,910 new instances of bone and joint cancer in the U.S. in 2022. Since chemotherapy for cancer has a huge impact on the bone, there is a high chance of losing bone mass and fractures, which demand bone densitometers by enhancing the global market revenue in the region. The presence of significant market players, top manufacturing units, and advanced hospitals are all boosting the market growth in the region. 

The Asia Pacific region is expected to grow the fastest in the global bone densitometer market during the forecast period due to the rising prevalence of osteoporosis and osteopenia among people, majorly observed in females. The growing government initiatives to bring awareness among the people regarding diseases and their prevention, diagnosis, and treatment options are expected to increase the demand for bone densitometers in the upcoming years.

KEY MARKET PLAYERS:

GE Healthcare Hologic Inc., DMS Imaging, Swissray International Inc., Xingaoyi Medical Equipment Co. Ltd., Eurotec Medical Systems, Trivitron Healthcare, OsteoSys Corporation, Scanflex Healthcare AB, Medonica Co. Ltd are some of the key market players in the bone densitometers market.

RECENT MARKET DEVELOPMENTS:

• In 2023, Hologic Inc., a leading company, followed by GE Healthcare, where these companies led the market with diverse and affordable portfolios of DXA machines. 
• In March 2022, Aurora Spine Corporation launched the implantation Bone Density Matched DEXA-C Cervical Interbody Fusion Device for the first time. The Aurora Spine's DEXA-C implant refers to the new age of individualized spine surgery. This reduces implant subsidence and speeds up fusion even in healthy people; it makes spine surgery more accessible to older individuals. 
• In July 2021, The FUJIFILM Healthcare Group's white-label production extended the contract with DMS Imaging to expand its bone densitometry in Africa and the Middle East.